<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1405" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1405/" /><meta name="ncbi_pagename" content="Jervell and Lange-Nielsen Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Jervell and Lange-Nielsen Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Jervell and Lange-Nielsen Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/08/17" /><meta name="citation_author" content="Lisbeth Tranebjærg" /><meta name="citation_author" content="Ricardo A Samson" /><meta name="citation_author" content="Glenn Edward Green" /><meta name="citation_pmid" content="20301579" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1405/" /><meta name="citation_keywords" content="JLNS" /><meta name="citation_keywords" content="JLNS" /><meta name="citation_keywords" content="Surdo Cardiac Syndrome" /><meta name="citation_keywords" content="Potassium voltage-gated channel subfamily E member 1" /><meta name="citation_keywords" content="Potassium voltage-gated channel subfamily KQT member 1" /><meta name="citation_keywords" content="KCNE1" /><meta name="citation_keywords" content="KCNQ1" /><meta name="citation_keywords" content="Jervell and Lange-Nielsen Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Jervell and Lange-Nielsen Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Lisbeth Tranebjærg" /><meta name="DC.Contributor" content="Ricardo A Samson" /><meta name="DC.Contributor" content="Glenn Edward Green" /><meta name="DC.Date" content="2017/08/17" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1405/" /><meta name="description" content="Jervell and Lange-Nielsen syndrome (JLNS) is characterized by congenital profound bilateral sensorineural hearing loss and long QTc, usually &gt;500 msec. Prolongation of the QTc interval is associated with tachyarrhythmias, including ventricular tachycardia, episodes of torsade de pointes ventricular tachycardia, and ventricular fibrillation, which may culminate in syncope or sudden death. Iron-deficient anemia and elevated levels of gastrin are also frequent features of JLNS. The classic presentation of JLNS is a deaf child who experiences syncopal episodes during periods of stress, exercise, or fright. Fifty percent of individuals with JLNS had cardiac events before age three years. More than half of untreated children with JLNS die before age 15 years." /><meta name="og:title" content="Jervell and Lange-Nielsen Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Jervell and Lange-Nielsen syndrome (JLNS) is characterized by congenital profound bilateral sensorineural hearing loss and long QTc, usually &gt;500 msec. Prolongation of the QTc interval is associated with tachyarrhythmias, including ventricular tachycardia, episodes of torsade de pointes ventricular tachycardia, and ventricular fibrillation, which may culminate in syncope or sudden death. Iron-deficient anemia and elevated levels of gastrin are also frequent features of JLNS. The classic presentation of JLNS is a deaf child who experiences syncopal episodes during periods of stress, exercise, or fright. Fifty percent of individuals with JLNS had cardiac events before age three years. More than half of untreated children with JLNS die before age 15 years." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1405/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/jln/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1405/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE89310DDFC89BC100000000030C0174.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1405_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1405_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/iso-def/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/joubert/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1405_"><span class="title" itemprop="name">Jervell and Lange-Nielsen Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: JLNS</div><p class="contrib-group"><span itemprop="author">Lisbeth Tranebj&#x000e6;rg</span>, MD, PhD, <span itemprop="author">Ricardo A Samson</span>, MD, and <span itemprop="author">Glenn Edward Green</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1405_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1405_ai__"><div class="contrib half_rhythm"><span itemprop="author">Lisbeth Tranebj&#x000e6;rg</span>, MD, PhD<div class="affiliation small">Professor of Medical Genetics and Genetic Audiology<br />Department of Clinical Genetics<br />Rigshospitalet/The Kennedy Center</div><div class="affiliation small">Institute of Clinical Medicine<br />The Panum Institute<br />University of Copenhagen<br />Copenhagen, Denmark<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="kd.hnoiger@greajbenart.htebsil" class="oemail">kd.hnoiger@greajbenart.htebsil</a><span style="unicode-bidi: bidi-override; direction: ltr;">; </span><a href="mailto:dev@null" data-email="kd.uk.dnus@greajbenart" class="oemail">kd.uk.dnus@greajbenart</a><div></div></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Ricardo A Samson</span>, MD<div class="affiliation small">Director of Electrophysiology<br />Children&#x02019;s Heart Center Nevada<br />Las Vegas, Nevada<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.retnectraehsnerdlihc@nosmasr" class="oemail">moc.retnectraehsnerdlihc@nosmasr</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Glenn Edward Green</span>, MD<div class="affiliation small">Department of Otolaryngology / Head and Neck Surgery<br />University of Michigan<br />Ann Arbor, Michigan<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.hcimu.dem@neergeg" class="oemail">ude.hcimu.dem@neergeg</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">July 29, 2002</span>; Last Update: <span itemprop="dateModified">August 17, 2017</span>.</p><p><em>Estimated reading time: 25 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="jln.Summary" itemprop="description"><h2 id="_jln_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Jervell and Lange-Nielsen syndrome (JLNS) is characterized by <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> profound bilateral sensorineural hearing loss and long QTc, usually &#x0003e;500 msec. Prolongation of the QTc interval is associated with tachyarrhythmias, including ventricular tachycardia, episodes of <i>torsade de pointes</i> ventricular tachycardia, and ventricular fibrillation, which may culminate in syncope or sudden death. Iron-deficient anemia and elevated levels of gastrin are also frequent features of JLNS. The classic presentation of JLNS is a deaf child who experiences syncopal episodes during periods of stress, exercise, or fright. Fifty percent of individuals with JLNS had cardiac events before age three years. More than half of untreated children with JLNS die before age 15 years.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of JLNS is established in a child with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> sensorineural deafness, long QT interval, and presence of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in either <i>KCNQ1</i> or <i>KCNE1</i>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Cochlear implantation to treat hearing loss; beta-adrenergic blockers for long QT interval (Note: Beta-blocker treatment is only partially effective.); implantable cardioverter defibrillators (ICDs) for those with a history of cardiac arrest and/or failure to respond to other treatments; ensure availability of automated external defibrillators where appropriate; standard treatment for those with iron-deficiency anemia.</p><p><i>Prevention of secondary complications</i>: Special precautions during anesthesia are necessary because of the increased risk for cardiac arrhythmia.</p><p><i>Surveillance:</i> Beta-blocker dose should be regularly assessed for efficacy and adverse effects, with evaluation every three to six months during rapid growth phases; periodic evaluations of ICDs for inappropriate shocks and pocket or lead complications.</p><p><i>Agents/circumstances to avoid:</i> Drugs that cause further prolongation of the QT interval; activities known to precipitate syncopal events in persons with long QT syndrome.</p><p><i>Evaluation of relatives at risk:</i> Hearing evaluation by standard newborn hearing screening programs and electrocardiograms for at-risk sibs; <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> to confirm the diagnosis if the pathogenic variants in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member are known.</p><p><i>Pregnancy management</i>: Consideration should be given as to whether a mother who has a fetus <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with JLNS herself has long QT syndrome.</p><p><i>Other:</i> Training for family members in cardiopulmonary resuscitation; use of an ID bracelet explaining the diagnosis; notifying local emergency medical services of high-risk persons with JLNS.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>JLNS is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. Parents of a child with JLNS are usually heterozygotes; rarely, only one parent is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> (i.e., the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has one inherited and one <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>). Parents may or may not have the long QT syndrome (LQTS) <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual usually has a 25% chance of being affected with JLNS, a 50% chance of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a JLNS-causing pathogenic variant and potentially at risk for LQTS, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the pathogenic variants in the family are known.</p></div></div><div id="jln.Diagnosis"><h2 id="_jln_Diagnosis_">Diagnosis</h2><div id="jln.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Jervell and Lange-Nielsen syndrome (JLNS) <b>should be suspected</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the following features:</p><ul><li class="half_rhythm"><div>Profound <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> sensorineural deafness</div></li><li class="half_rhythm"><div>Long QTc interval (&#x0003e;500 msec), often manifest as syncope, most often elicited by emotion or exercise. Note: Normal QTc interval in males is &#x0003c;440 msec and in post-pubertal females is &#x0003c;460 msec.</div></li></ul></div><div id="jln.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of JLNS <b>is</b>
<b>established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the above suggestive findings. Identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in either <i>KCNQ1</i> or <i>KCNE1</i> confirms the diagnosis, particularly if clinical features are inconclusive.</p><p>Note: (1) It is not currently known how many children with molecularly confirmed JLNS have a borderline QTc interval (440-500 msec) or a normal QTc interval. (2) Hearing loss commonly occurs in individuals with <a href="/books/n/gene/rws/">long QT syndrome</a> (LQTS). The hearing loss may be entirely unrelated to the etiology of the LQTS, particularly if the hearing loss is moderate.</p><p>Molecular genetic testing approaches can include <b>serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>KCNQ1</i> is performed first and followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found. If only one or no <i>KCNQ1</i> pathogenic variant is identified, <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>KCNE1</i> should be performed next.</div><div class="half_rhythm">In countries with <i>KCNQ1</i> founder variants (e.g., Norway) <i>KCNQ1</i> sequencing should be carried out with knowledge of these variants to ensure they will be detected (see <a href="#jln.Molecular_Genetics">Molecular Genetics</a>) [<a class="bk_pop" href="#jln.REF.tranebj_rg.1999.137">Tranebj&#x000e6;rg et al 1999</a>, <a class="bk_pop" href="#jln.REF.tranebj_rg.2004">Tranebj&#x000e6;rg 2004</a>, <a class="bk_pop" href="#jln.REF.berge.2008.362">Berge et al 2008</a>, <a class="bk_pop" href="#jln.REF.siem.2008.261">Siem et al 2008</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>KCNE1, KCNQ1</i> and other genes of interest (see <a href="#jln.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, mitochondrial sequencing, and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or genes that results in a similar clinical presentation). For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="jln.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Jervell and Lange-Nielsen Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1405/table/jln.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__jln.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1,&#x000a0;2</sup></th><th id="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of JLNS Attributed to Pathogenic Variants in This Gene</th><th id="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>3</sup> Detectable by Test Method</th></tr><tr><th headers="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></th><th headers="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></th></tr></thead><tbody><tr><td headers="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCNE1</i></td><td headers="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;10%&#x000a0;<sup>6</sup></td><td headers="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_jln.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~100%&#x000a0;<sup>7</sup></td><td headers="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_jln.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 8</td></tr><tr><td headers="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCNQ1</i></td><td headers="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~90%&#x000a0;<sup>6</sup></td><td headers="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_jln.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;95%</td><td headers="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_jln.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 family&#x000a0;<sup>9,&#x000a0;10</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="jln.TF.1.1"><p class="no_margin">Genes are listed alphabetically.</p></div></dd><dt>2. </dt><dd><div id="jln.TF.1.2"><p class="no_margin">See <a href="/books/NBK1405/#jln.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>3. </dt><dd><div id="jln.TF.1.3"><p class="no_margin">See <a href="#jln.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>4. </dt><dd><div id="jln.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="jln.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods that may be used include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="jln.TF.1.6"><p class="no_margin">In a study of ten families, nine had pathogenic variants in <i>KCNQ1</i> [<a class="bk_pop" href="#jln.REF.tyson.2000.499">Tyson et al 2000</a>]. Of 63 families, six (9.5%) had pathogenic variants in <i>KCNE1</i> [<a class="bk_pop" href="#jln.REF.schwartz.2006.783">Schwartz et al 2006</a>]. None of the individuals of Norwegian ancestry with JLNS have been shown to have <i>KCNE1</i> pathogenic variants [<a class="bk_pop" href="#jln.REF.tranebj_rg.1999.137">Tranebj&#x000e6;rg et al 1999</a>, <a class="bk_pop" href="#jln.REF.berge.2008.362">Berge et al 2008</a>, <a class="bk_pop" href="#jln.REF.siem.2008.261">Siem et al 2008</a>]. Pathogenic variants have been found in either <i>KCNQ1</i> or <i>KCNE1</i> in 94% of individuals with clinical JLNS undergoing molecular testing [<a class="bk_pop" href="#jln.REF.schwartz.2006.783">Schwartz et al 2006</a>].</p></div></dd><dt>7. </dt><dd><div id="jln.TF.1.7"><p class="no_margin">Three variants in <i>KCNE1</i>, all detectable by <a class="def" href="/books/n/gene/glossary/def-item/sanger-sequencing/">Sanger sequencing</a>, have been associated with JLNS [<a class="bk_pop" href="#jln.REF.schulzebahr.1997.267">Schulze-Bahr et al 1997</a>, <a class="bk_pop" href="#jln.REF.tyson.1997.2179">Tyson et al 1997</a>].</p></div></dd><dt>8. </dt><dd><div id="jln.TF.1.8"><p class="no_margin">No deletions or duplications of <i>KCNE1</i> have been reported to cause JLNS.</p></div></dd><dt>9. </dt><dd><div id="jln.TF.1.9"><p class="no_margin"><a class="bk_pop" href="#jln.REF.sung.2014.395">Sung et al [2014]</a></p></div></dd><dt>10. </dt><dd><div id="jln.TF.1.10"><p class="no_margin">Both <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> and <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> of one or more exons of <i>KCNQ1</i> are known to cause long QT syndrome [<a class="bk_pop" href="#jln.REF.zehelein.2006.35397">Zehelein et al 2006</a>, <a class="bk_pop" href="#jln.REF.eddy.2008.1275">Eddy et al 2008</a>, <a class="bk_pop" href="#jln.REF.sung.2014.395">Sung et al 2014</a>]; their frequency is unknown.</p></div></dd></dl></div></div></div></div></div><div id="jln.Clinical_Characteristics"><h2 id="_jln_Clinical_Characteristics_">Clinical Characteristics</h2><div id="jln.Clinical_Description"><h3>Clinical Description</h3><p>The classic presentation of JLNS is a deaf child who experiences syncopal episodes during periods of stress, exercise, or fright.</p><p><b>Hearing loss.</b> All individuals with molecularly confirmed JLNS have profound bilateral <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> sensorineural deafness (see <a href="/books/n/gene/deafness-overview/">Deafness and Hereditary Hearing Loss Overview</a>).</p><p><b>Long QTc.</b> Individuals with JLNS have a QTc interval greater than 500 msec (average 550 msec), indicating increased time for ventricular depolarization and repolarization [<a class="bk_pop" href="#jln.REF.winbo.2012.1799">Winbo et al 2012</a>, <a class="bk_pop" href="#jln.REF.winbo.2014.22">Winbo et al 2014</a>]. Abnormal cardiac depolarization and repolarization may result in tachyarrhythmias (including ventricular tachycardia, episodes of <i>torsade de pointes</i> ventricular tachycardia, and ventricular fibrillation), which may culminate in syncope or sudden death.</p><p>QTc prolongation in JLNS, particularly when severe, appears to be associated with increased risk for death in infancy (SIDS). In the <a class="bk_pop" href="#jln.REF.schwartz.2006.783">Schwartz et al [2006]</a> study of 135 families with JLNS, the QTc was markedly prolonged (557&#x000b1;65 msec); 50% of individuals had cardiac events before age three years, with emotion and exercise being the primary triggers. Although more than half of untreated children with JLNS die before age 15 years, some individuals are reported to have survived several syncopal episodes during adulthood. Note, however, that selection bias for severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals cannot be excluded: individuals with putative JLNS but no clinical manifestations other than deafness until adulthood (and to age 50 years in one individual) have been described.</p><p><b>Anemia.</b> Individuals with <i>KCNQ1</i>-related JLNS have an increased incidence of iron deficiency anemia and hypergastrinemia [<a class="bk_pop" href="#jln.REF.winbo.2013.325">Winbo et al 2013</a>]. This may be due to loss of the KCNQ1 potassium channels and reduced gastric acid secretion.</p><p><b>Other.</b> The sex ratio among individuals with JLNS is even, but females are at lower risk for cardiac arrest/sudden death [<a class="bk_pop" href="#jln.REF.schwartz.2006.783">Schwartz et al 2006</a>]. Vestibular dysfunction was found in 14/14 deaf individuals with JLNS, irrespective of previous cochlear implantation. The proposed mechanism was disruption of the endolymph homeostasis [<a class="bk_pop" href="#jln.REF.winbo.2015.7">Winbo &#x00026; Rydberg 2015</a>]</p><p>Physical examination is unremarkable except for deafness.</p><p><b>Heterozygotes.</b> Individuals who are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for pathogenic variants associated with JLNS usually have normal hearing. In some heterozygotes, QTc prolongation, fainting, and sudden death never occur. In contrast, some individuals heterozygous for pathogenic variants associated with JLNS may have QTc prolongation associated with fainting and death heritable in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. This form of LQTS is called <a href="/books/n/gene/rws/">Romano-Ward syndrome</a> (RWS).</p><p><b>Histopathology of temporal bone.</b> Histologic examination of a few temporal bones was performed prior to the availability of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, but not since. In one Norwegian individual with JLNS resulting from homozygosity for the c.572_576del <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KCNQ1</i>, histopathologic examination of the temporal bones showed severe atrophy of the stria vascularis and the organ of Corti with absence of cochlear nerve fibers [Tranebj&#x000e6;rg L &#x00026; Merchant SM, unpublished data (2012)].</p></div><div id="jln.Phenotype_Correlations_by_Gene"><h3>Phenotype Correlations by Gene</h3><p>Among six asymptomatic individuals reported by <a class="bk_pop" href="#jln.REF.schwartz.2006.783">Schwartz et al [2006]</a>, two had <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>KCNQ1</i> pathogenic variants and four had biallelic <i>KCNE1</i> pathogenic variants, further confirming the milder presentation of JLNS associated with <i>KCNE1</i> pathogenic variants compared to JLNS associated with <i>KCNQ1</i> pathogenic variants.</p><p><b><i>KCNQ1</i>.</b> Individuals with <i>KCNQ1</i>-related JLNS have an increased incidence of iron deficiency anemia and hypergastrinemia [<a class="bk_pop" href="#jln.REF.winbo.2013.325">Winbo et al 2013</a>].</p></div><div id="jln.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Among 63 individuals who were genotyped, 33% were compound heterozygotes [<a class="bk_pop" href="#jln.REF.schwartz.2006.783">Schwartz et al 2006</a>]. No clinical difference was evident between persons with at least one <a class="def" href="/books/n/gene/glossary/def-item/inactivating/">inactivating</a> variant (e.g., <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a>/<a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, splice variant, truncation) and those with <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants.</p></div><div id="jln.Nomenclature"><h3>Nomenclature</h3><p>Lange-Nielsen syndrome has also been called cardioauditory syndrome of Jervell and Lange-Nielsen and surdo-cardiac syndrome.</p><p>JLNS is now appreciated to be a true syndrome, in which the cardiac and cochlear pathologies are attributable to a common molecular etiology. Although there are several case reports in the older literature of individuals with long QT syndrome and non-profound hearing loss, in many of these reports it is likely that the hearing loss and prolonged QT interval have different etiologies (see <a href="#jln.Differential_Diagnosis">Differential Diagnosis</a>).</p></div><div id="jln.Prevalence"><h3>Prevalence</h3><p>Prevalence varies depending on the population studied:</p><ul><li class="half_rhythm"><div>Norway has an unusually high prevalence of at least one in 200,000 [<a class="bk_pop" href="#jln.REF.tranebj_rg.1999.137">Tranebj&#x000e6;rg et al 1999</a>]. This prevalence stems from four Norwegian founder variants [<a class="bk_pop" href="#jln.REF.berge.2008.362">Berge et al 2008</a>, <a class="bk_pop" href="#jln.REF.siem.2008.261">Siem et al 2008</a>, <a class="bk_pop" href="#jln.REF.winbo.2012.1799">Winbo et al 2012</a>].</div></li><li class="half_rhythm"><div>Sweden also has a prevalence of one in 200,000 based on a study of preadolescent children, identifying 19 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals from 13 families. Eight <i>KCNQ1</i> pathogenic variants were identified, of which p.Arg518Ter constituted 12/24 alleles [<a class="bk_pop" href="#jln.REF.winbo.2012.1799">Winbo et al 2012</a>]. Founder variants accounted for 83% of pathogenic variants [<a class="bk_pop" href="#jln.REF.winbo.2014.22">Winbo et al 2014</a>].</div></li><li class="half_rhythm"><div>In a study of 350 children with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> deafness in Turkey, one in 175 had JLNS [<a class="bk_pop" href="#jln.REF.ocal.1997.401">Ocal et al 1997</a>].</div></li><li class="half_rhythm"><div>A particular <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> <i>KCNQ1</i> variant has been identified in the <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> state in <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> LQTS and in the <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> state in JLNS in a few individuals from Finland; however, prevalence of JLNS was not increased in Finland [<a class="bk_pop" href="#jln.REF.piippo.2001.562">Piippo et al 2001</a>].</div></li><li class="half_rhythm"><div>An overview of worldwide occurrence was published by <a class="bk_pop" href="#jln.REF.tranebj_rg.2004">Tranebj&#x000e6;rg [2004]</a></div></li></ul><p>These data are the best available; however, diagnostic criteria using a QTc &#x0003e;440 msec in children are likely to include some false positives, perhaps as many as 15%-20% [<a class="bk_pop" href="#jln.REF.allan.2001.178">Allan et al 2001</a>]. The design of the review by <a class="bk_pop" href="#jln.REF.schwartz.2006.783">Schwartz et al [2006]</a> did not allow refinement of prevalence estimates.</p></div></div><div id="jln.Genetically_Related_Allelic_Disorder"><h2 id="_jln_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p>Heterozygosity for pathogenic variants in <i>KCNQ1</i> and <i>KCNE1</i> has been observed in children without hearing loss who have long QT syndrome (LQTS) inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner [<a class="bk_pop" href="#jln.REF.towbin.2001.574">Towbin et al 2001</a>] (also called <a href="/books/n/gene/rws/">Romano-Ward syndrome</a>) (see <a href="#jln.Differential_Diagnosis">Differential Diagnosis</a>).</p></div><div id="jln.Differential_Diagnosis"><h2 id="_jln_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Deafness and prolonged QTc</b> with or without long QT syndrome (LQTS) both have multiple etiologies, including genetic and environmental causes. In many individuals with both deafness and prolonged QTc (or LQTS), the deafness and prolonged QTc (or LQTS) have separate etiologies. All of these possibilities must be considered in each <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, particularly in the absence of parental <a class="def" href="/books/n/gene/glossary/def-item/consanguinity/">consanguinity</a> or an affected sib. The following considerations are relevant in an individual who has both deafness and prolonged QTc:</p><ul><li class="half_rhythm"><div>Prior to the availability of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, the diagnosis of Jervell and Lange-Nielsen syndrome (JLNS) was based on clinical criteria alone. (Romano-Ward syndrome was commonly diagnosed in persons with LQTS and normal hearing.)</div></li><li class="half_rhythm"><div>Some children with JLNS may be misdiagnosed with epilepsy and incorrectly treated with antiepileptic drugs before the correct diagnosis of JLNS is established [<a class="bk_pop" href="#jln.REF.tranebj_rg.1999.137">Tranebj&#x000e6;rg et al 1999</a>].</div></li></ul><p><a href="/books/n/gene/rws/"><b>Long QT syndrome</b></a><b>.</b> Long QT multigene panels may include testing for a number of the genes related to disorders discussed in this section. Note: The genes involved and methods used vary by laboratory.</p><p><b>Romano-Ward syndrome.</b> The term "Romano-Ward syndrome" (RWS) refers to forms of long QT syndrome with a purely cardiac electrophysiologic disorder, inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner (LQTS types 1-3, type 5, type 6, and types 9-15). RWS is characterized by QT prolongation and T-wave abnormalities on ECG and the ventricular tachycardia <i>torsade de pointes</i> (TdP). The diagnosis of RWS is made on the basis of a prolonged QT interval on ECG, clinical presentation, and family history; or identification of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in one or more of the 15 genes known to be associated with LQTS (of which <i>KCNQ1</i>, <i>KCNH2</i>, and <i>SCN5A</i> are the most common) in the absence of profound <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> sensorineural deafness (the presence of which is highly suggestive of Jervell and Lange-Nielsen syndrome). Individuals with pathogenic variants in <i>KCNE1</i> may also have atrial fibrillation [<a class="bk_pop" href="#jln.REF.olesen.2012.24">Olesen et al 2012</a>]. Diagnostic criteria have been established for the resting ECG QTc value in the absence of specific conditions known to lengthen the QTc interval. For a summary of the genes known to be associated with RWS, see <a href="/books/n/gene/rws/">Long QT Syndrome</a>. Only <i>KCNQ1</i> and <i>KCNE1</i> have been implicated in both RWS and JLNS.</p><p><a href="/books/n/gene/timothy/"><b>Timothy syndrome</b></a> is a multisystem disorder characterized by cardiac, hand/foot, facial, and neurodevelopmental features. Typical cardiac findings include a rate-corrected QT interval &#x0003e;480 msec, functional 2:1 AV block with bradycardia, tachyarrhythmias, and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defects (patent ductus arteriosus, patent foramen ovale, ventricular septal defect, tetralogy of Fallot, hypertrophic cardiomyopathy).</p><p><a href="/books/n/gene/acpp/"><b>Andersen-Tawil syndrome</b></a> is characterized by a triad of episodic flaccid muscle weakness (i.e., periodic paralysis), ventricular arrhythmias and prolonged QT interval, and anomalies including low-set ears, widely spaced eyes, small mandible, fifth-digit clinodactyly, syndactyly, short stature, and scoliosis.</p><p>Acquired causes of QTc interval prolongation include the following:</p><ul><li class="half_rhythm"><div>Electrolyte abnormalities: hypokalemia, hypomagnesemia, hypocalcemia</div></li><li class="half_rhythm"><div>Malnutrition or liquid protein diet</div></li><li class="half_rhythm"><div>Drugs: vasodilators, tricyclic antidepressants, organophosphates, antihistamines, phenothiazines, procainamide, disopyramide, quinidine, and many others. For a complete, updated list see <a href="http://www.crediblemeds.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.crediblemeds.org</a> (registration required).</div></li><li class="half_rhythm"><div>Primary myocardial problems: cardiomyopathy, myocarditis, ischemia</div></li><li class="half_rhythm"><div>Central nervous or autonomic system injury; subarachnoid hemorrhage; stellate ganglion blockade</div></li></ul><p><b>Hearing loss.</b> The differential diagnosis for hearing loss includes consideration of other forms of <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> and nonsyndromic disorders, as well as acquired disorders. For more information on hereditary hearing loss, see <a href="/books/n/gene/deafness-overview/">Deafness and Hereditary Hearing Loss Overview</a>.</p><p>One disorder that should be noted specifically is <a href="/books/n/gene/dfnb1/">DFNB1</a>, the most common <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> form of nonsyndromic hearing loss. DFNB1 is characterized by <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a>, non-progressive, mild-to-profound sensorineural hearing impairment. No other associated medical findings are present. Diagnosis of DFNB1 depends on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> to identify <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>GJB2</i> (sequence variants as well as variants in upstream <a class="def" href="/books/n/gene/glossary/def-item/cis/"><i>cis</i></a>-regulatory elements [<i>GJB6</i> deletions] that alter expression of the gap junction beta-2 protein [connexin 26]). JLNS should be suspected in any infant who has profound bilateral sensorineural hearing loss, no identifiable <i>GJB2</i> pathogenic variants, and a normal physical examination.</p><p><a href="/books/n/gene/brugada/"><b>Brugada syndrome</b></a> is characterized by cardiac conduction abnormalities (ST-segment abnormalities in leads V1-V3 on ECG and a high risk for ventricular arrhythmias) that can result in sudden death.</p><p><b>Sudden infant death syndrome (SIDS)</b> (OMIM <a href="http://omim.org/entry/272120" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">272120</a>). Data from multicenter studies indicate that 9.5% of infants with SIDS may be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for functionally significant variants in one of the known LQTS-related genes. Sudden arrhythmic death may thus be an important contributor to SIDS; it is unknown what proportion of infants with SIDS have or would develop profound hearing impairment. Implementation of universal neonatal hearing screening, supplemented with early electrocardiography, may have the potential to identify high-risk children. However, a recent large population study did not find a higher incidence of JLNS in newborns identified with hearing loss by universal screening [<a class="bk_pop" href="#jln.REF.chang.2014">Chang et al 2014</a>].</p></div><div id="jln.Management"><h2 id="_jln_Management_">Management</h2><div id="jln.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Jervell and Lange-Nielsen syndrome (JLNS), the following evaluations are recommended if they have not already been completed:</p><ul><li class="half_rhythm"><div>Formal audiology evaluation for extent of hearing loss</div></li><li class="half_rhythm"><div>Cardiac examination including calculation of QTc</div></li><li class="half_rhythm"><div>A three-generation family history that focuses on cardiac disease, syncope, and hearing ability</div></li><li class="half_rhythm"><div>Complete blood count to screen for anemia. If anemia is present, screening for iron deficiency is recommended.</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist</div></li></ul></div><div id="jln.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Hearing loss</b> in JLNS may be treated successfully with cochlear implantation, an intervention that does not interfere with bipolar pacemakers [<a class="bk_pop" href="#jln.REF.green.2000.27">Green et al 2000</a>, <a class="bk_pop" href="#jln.REF.chorbachi.2002.213">Chorbachi et al 2002</a>] (see <a href="/books/n/gene/deafness-overview/">Deafness and Hereditary Hearing Loss Overview</a>). To date, the cumulative published experience includes approximately 20 individuals with JLNS who have received cochlear implantation. Of note, the diagnosis of JLNS was only verified with <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> in four Norwegian individuals, all of whom had pathogenic variants in <i>KCNQ1.</i> An increase in sound-related syncopal episodes was noted after cochlear implantation in one child [<a class="bk_pop" href="#jln.REF.alaama.2015.74">Al-Aama et al 2015</a>].</p><p>Note: Although cochlear implantation appears to be safe, special precautions are necessary during anesthesia because of the increased risk for cardiac arrhythmia [<a class="bk_pop" href="#jln.REF.daneshi.2008.314">Daneshi et al 2008</a>, <a class="bk_pop" href="#jln.REF.siem.2008.261">Siem et al 2008</a>, <a class="bk_pop" href="#jln.REF.yanmei.2008.1723">Yanmei et al 2008</a>]. One <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual died during a perioperative cardiac arrest [<a class="bk_pop" href="#jln.REF.broomfield.2010.163">Broomfield et al 2010</a>].</p><p><b>Cardiac issues.</b> The main goal in management of JLNS is prevention of syncope, cardiac arrest, and sudden death. Note that efficacy of beta-blocker treatment is only partial: 51% of treated individuals had cardiac events and 27% had cardiac arrest or sudden death. Even with additional therapies (e.g., pacemaker, implantable cardioverter/defibrillator, left sympathetic denervation), 18 (56%) of 32 individuals experienced additional symptoms, including sudden death in seven [<a class="bk_pop" href="#jln.REF.schwartz.2006.783">Schwartz et al 2006</a>].</p><ul><li class="half_rhythm"><div>Administration of beta-adrenergic blockers has been the traditional first-line medical therapy for cardiac events, but more aggressive, immediate treatment may be appropriate. Cardiac events in JLNS frequently occur despite beta blockade [<a class="bk_pop" href="#jln.REF.schwartz.2006.783">Schwartz et al 2006</a>]. <a class="bk_pop" href="#jln.REF.goldenberg.2006.1161">Goldenberg et al [2006]</a> demonstrated markedly increased mortality in individuals with JLNS treated exclusively with beta blockers in comparison to individuals with Romano-Ward syndrome. A mortality rate of 35% over five years was observed for individuals receiving beta blockers exclusively; 86% of individuals treated exclusively with beta blockers experienced a cardiac event. The interactions of beta blockers with other medical conditions (e.g., asthma, diabetes mellitus, depression) should also be considered. Propranolol and nadolol have been shown to be more effective than metoprolol in suppressing cardiac events [<a class="bk_pop" href="#jln.REF.chockalingam.2012.2092">Chockalingam et al 2012</a>, <a class="bk_pop" href="#jln.REF.winbo.2014.22">Winbo et al 2014</a>]. A recent consensus statement advocates use of nadolol as the preferred beta blocker for drug therapy of individuals with long QT syndrome [<a class="bk_pop" href="#jln.REF.ackerman.2017.e41">Ackerman et al 2017</a>].</div></li><li class="half_rhythm"><div>Implantable cardioverter defibrillators (ICDs) should be considered in individuals with a history of cardiac arrest or failure to respond to other treatments [<a class="bk_pop" href="#jln.REF.goel.2004.370">Goel et al 2004</a>]. More recent recommendations have strongly urged ICD placement for high-risk individuals, defined by the following criteria [<a class="bk_pop" href="#jln.REF.schwartz.2006.783">Schwartz et al 2006</a>]:</div><ul><li class="half_rhythm"><div>QTc interval &#x0003e;550 msec</div></li><li class="half_rhythm"><div>Syncope before age five years</div></li><li class="half_rhythm"><div>Male gender, age &#x0003e;20 years with <i>KCNQ1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a></div></li></ul></li><li class="half_rhythm"><div>The risk for sudden cardiac death appears to be low in individuals younger than age five years, but medical therapy should be administered early in these high-risk individuals and ICD placement considered after age five years [<a class="bk_pop" href="#jln.REF.richter.2006.1169">Richter &#x00026; Brugada 2006</a>].</div></li><li class="half_rhythm"><div>In certain cases, the availability of automated external defibrillators in the home, workplace, or school may be applicable, as is appropriate CPR training of family members and those who have regular contact with individuals with JLNS.</div></li><li class="half_rhythm"><div>Left cardiac sympathetic denervation has been effective for some individuals.</div></li></ul><p><b>Iron deficiency anemia.</b> The treatment of iron deficiency anemia should follow standard guidelines.</p></div><div id="jln.Prevention_of_Primary_Manifestations"><h3>Prevention of Primary Manifestations</h3><p>See <a href="#jln.Treatment_of_Manifestations">Treatment of Manifestations</a> regarding prevention of syncope, cardiac arrest, and sudden death.</p></div><div id="jln.Prevention_of_Secondary_Complication"><h3>Prevention of Secondary Complications</h3><p>Special precautions during anesthesia are necessary because of the increased risk for cardiac arrhythmia [<a class="bk_pop" href="#jln.REF.daneshi.2008.314">Daneshi et al 2008</a>, <a class="bk_pop" href="#jln.REF.siem.2008.261">Siem et al 2008</a>, <a class="bk_pop" href="#jln.REF.yanmei.2008.1723">Yanmei et al 2008</a>].</p></div><div id="jln.Surveillance"><h3>Surveillance</h3><p>Beta-blocker dose should be regularly assessed for efficacy and adverse effects, and doses altered as needed. Because dose adjustment is especially important in growing children, evaluation is appropriate every three to six months during rapid growth phases.</p><p>Regular, periodic evaluation of implantable cardioverter defibrillators (ICDs) for inappropriate shocks and pocket or lead complications is indicated.</p></div><div id="jln.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>The following should be avoided:</p><ul><li class="half_rhythm"><div>Drugs that cause further prolongation of the QT interval or provoke <i>torsade de pointes</i>; see <a href="http://www.crediblemeds.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.crediblemeds.org</a> for a complete and updated list (registration required).</div></li><li class="half_rhythm"><div>Triggers for intense or sudden emotion; activities that are known to precipitate syncopal events in individuals with long QT syndrome, including:</div><ul><li class="half_rhythm"><div>Competitive sports</div></li><li class="half_rhythm"><div>Amusement park rides</div></li><li class="half_rhythm"><div>Frightening movies</div></li><li class="half_rhythm"><div>Jumping into cold water</div></li></ul></li></ul><p>A cardiologist should make recommendations for activity restrictions based on the effectiveness of medical intervention.</p></div><div id="jln.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate sibs and parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> in order to identify as early as possible those who would benefit from initiation of treatment and preventive measures.</p><ul><li class="half_rhythm"><div>If the pathogenic variants in the family are known, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can be used to clarify the genetic status of at-risk family members.</div></li><li class="half_rhythm"><div>If the pathogenic variants in the family are not known, ECG testing should be undertaken to evaluate for QT prolongation.</div></li><li class="half_rhythm"><div>Standard <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> programs are sufficient to identify hearing loss in children with JLNS.</div></li></ul><p>Because of the relationship between JLNS and long QT syndrome, ECG should be considered for relatives at risk for JLNS even if they have normal hearing.</p><p>If the JLNS-causing pathogenic variants in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member are known, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of a relative with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> profound sensorineural hearing loss is recommended to confirm the diagnosis of JLNS.</p><p>See <a href="#jln.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="jln.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Consideration should be given as to whether a mother who has a fetus <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with JLNS herself has long QT syndrome [<a class="bk_pop" href="#jln.REF.seth.2007.1092">Seth et al 2007</a>].</p></div><div id="jln.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div><div id="jln.Other"><h3>Other</h3><p>Family members of individuals with JLNS should be trained in cardiopulmonary resuscitation (CPR) as up to 95% of individuals with JLNS have a cardiac event before adulthood [<a class="bk_pop" href="#jln.REF.schwartz.2006.783">Schwartz et al 2006</a>].</p><p>Affected individuals should wear an ID bracelet explaining their diagnosis.</p><p>It is appropriate to notify local emergency medical services (EMS) of high-risk persons, including those with JLNS [<a class="bk_pop" href="#jln.REF.hazinski.2004.278">Hazinski et al 2004</a>].</p></div></div><div id="jln.Genetic_Counseling"><h2 id="_jln_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="jln.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Jervell and Lange-Nielsen syndrome (JLNS) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="jln.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Parents of a child with JLNS are usually obligate heterozygotes (i.e., carriers of one <i>KCNQ1</i> or <i>KCNE1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>). In rare cases, only one parent is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> and the other pathogenic variant in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> [<a class="bk_pop" href="#jln.REF.schwartz.2000.262">Schwartz et al 2000</a>].</div></li><li class="half_rhythm"><div>Parents may or may not have the long QT syndrome (LQTS) <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Studies have documented <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance of moderately prolonged QTc intervals in some, but not all, families in which one or more sibs have JLNS [<a class="bk_pop" href="#jln.REF.splawski.1997.1562">Splawski et al 1997</a>].</div></li><li class="half_rhythm"><div>Recommendations for evaluation of the parents of a child with JLNS include:</div><ul><li class="half_rhythm"><div>Molecular genetic testing if the pathogenic variants have been identified;</div></li><li class="half_rhythm"><div>Comprehensive electrocardiographic testing for evidence of QTc prolongation by a physician familiar with LQTS.</div></li></ul></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>If both parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a JLNS-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (i.e., both of the variants identified in the proband are inherited), the typical risks at conception to each sib are:</div><ul><li class="half_rhythm"><div>A 25% chance of inheriting two pathogenic variants and being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with JLNS;</div></li><li class="half_rhythm"><div>A 50% chance of inheriting one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. A sib who inherits one pathogenic variant would not be expected to have JLNS but is at risk for LQTS if the inherited pathogenic variant is associated with the LQTS <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (approximately 67% of JLNS-associated pathogenic variants are also known to also be associated with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> LQTS) [<a class="bk_pop" href="#jln.REF.alaama.2015.74">Al-Aama et al 2015</a>];</div></li><li class="half_rhythm"><div>A 25% chance of inheriting neither of the pathogenic variants identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>. A sib who inherits neither of the JLNS-related pathogenic variants is not at increased risk for JLNS or, potentially, LQTS.</div></li></ul></li><li class="half_rhythm"><div>If only one parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a JLNS-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (i.e., the proband has one inherited and one <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant), sibs are not at increased risk for JLNS but 50% are potentially at risk for LQTS if the inherited pathogenic variant is associated with the LQTS <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</div></li><li class="half_rhythm"><div>Recommendations for evaluation of sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with JLNS include:</div><ul><li class="half_rhythm"><div>Audiology evaluation;</div></li><li class="half_rhythm"><div>Electrophysiologic evaluation for evidence of LQTS;</div></li><li class="half_rhythm"><div>Molecular genetic testing if the pathogenic variants in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> are known;</div></li><li class="half_rhythm"><div>Comprehensive electrocardiographic testing for evidence of QTc prolongation by a physician familiar with LQTS.</div></li></ul></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The offspring of an individual with JLNS inherit one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; thus, 100% of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s offspring are potentially at risk for LQTS.</div></li><li class="half_rhythm"><div>In the event that the reproductive partner of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is also <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the same <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which two pathogenic variants have been identified in the proband, the risk to offspring of having JLNS is 50%.</div></li><li class="half_rhythm"><div>Recommendations for evaluation of the offspring of an individual with JLNS include comprehensive electrocardiographic testing for evidence of QTc prolongation by a physician familiar with LQTS.</div></li></ul><p><b>Other family members.</b> Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents may also be at 50% risk of having a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KCNQ1</i> or <i>KCNE1</i> and at potential risk for LQTS.</p></div><div id="jln.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>KCNQ1</i> or <i>KCNE1</i> pathogenic variants in the family.</p></div><div id="jln.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#jln.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p>Because prolonged QTc interval in families with JLNS may follow an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance pattern, it is important that family members at risk undergo electrocardiographic testing for evidence of LQTS early in life. Individuals with LQTS are at increased risk for sudden death and thus require cardiologic intervention. The actual risk for LQTS in family members of individuals with JLNS is not known.</p><p>Individuals who are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a JLNS-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have a single pathogenic variant in a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> associated with LQTS that may cause QTc prolongation or LQTS in either a clinically significant or clinically insignificant form. Whether the variant is clinically significant or insignificant, it may be transmitted in a clinically significant fashion to future generations as either <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> LQTS (i.e., <a href="/books/n/gene/rws/">Romano-Ward syndrome</a>) or JLNS, a confusing phenomenon during <a class="def" href="/books/n/gene/glossary/def-item/pedigree/">pedigree</a> evaluation.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of genetic status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a>, or are at risk of being heterozygous.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="jln.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>KCNQ1</i> or <i>KCNE1</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and in families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="jln.Resources"><h2 id="_jln_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=jervellandlangenielsensyndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Jervell and Lange-Nielsen syndrome</a></div></li><li class="half_rhythm"><div><b>Sudden Arrhythmia Death Syndromes (SADS) Foundation</b></div><div>508 East South Temple</div><div>Suite #202</div><div>Salt Lake City UT 84102</div><div><b>Phone:</b> 800-786-7723 (toll-free); 801-531-0937</div><div><b>Email:</b> sads@sads.org</div><div><a href="http://www.sads.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.sads.org</a></div></li><li class="half_rhythm"><div><b>International Long QT Syndrome Registry</b></div><div>Heart Research Follow-Up Program</div><div>Box 653</div><div>Rochester NY 14642-8653</div><div><b>Phone:</b> 585-276-0016</div><div><b>Fax:</b> 585-273-5283</div><div><b>Email:</b> heartajm@heart.rochester.edu</div></li></ul></div><div id="jln.Molecular_Genetics"><h2 id="_jln_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="jln.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Jervell and Lange-Nielsen Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1405/table/jln.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__jln.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_jln.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_jln.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_jln.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_jln.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_jln.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_jln.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_jln.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/3753" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>KCNE1</i></a></td><td headers="hd_b_jln.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=3753" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">21q22<wbr style="display:inline-block"></wbr>​.12</a></td><td headers="hd_b_jln.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P15382" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Potassium voltage-gated channel subfamily E member 1</a></td><td headers="hd_b_jln.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://research.cchmc.org/LOVD2/home.php?select_db=KCNE1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CCHMC - Human Genetics Mutation Database (KCNE1)</a><br /><a href="https://lovd.nl/KCNE1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNE1 @ ZAC-GGM</a></td><td headers="hd_b_jln.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=KCNE1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNE1</a></td><td headers="hd_b_jln.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=KCNE1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNE1</a></td></tr><tr><td headers="hd_b_jln.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/3784" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>KCNQ1</i></a></td><td headers="hd_b_jln.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=3784" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">11p15<wbr style="display:inline-block"></wbr>​.5-p15.4</a></td><td headers="hd_b_jln.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P51787" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Potassium voltage-gated channel subfamily KQT member 1</a></td><td headers="hd_b_jln.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://research.cchmc.org/LOVD2/home.php?select_db=KCNQ1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNQ1 @ LOVD</a><br /><a href="https://lovd.nl/KCNQ1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNQ1 @ ZAC-GGM</a></td><td headers="hd_b_jln.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=KCNQ1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNQ1</a></td><td headers="hd_b_jln.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=KCNQ1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNQ1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="jln.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="jln.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Jervell and Lange-Nielsen Syndrome (<a href="/omim/176261,220400,607542,612347" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1405/table/jln.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__jln.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/176261" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">176261</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED SUBFAMILY, MEMBER 1; KCNE1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/220400" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">220400</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">JERVELL AND LANGE-NIELSEN SYNDROME 1; JLNS1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607542" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607542</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 1; KCNQ1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/612347" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">612347</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">JERVELL AND LANGE-NIELSEN SYNDROME 2; JLNS2</td></tr></tbody></table></div></div><div id="jln.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p>Jervell and Lange-Nielsen syndrome (JLNS) is caused by an aberration in a potassium channel found in the stria vascularis of the cochlea (inner ear) and the heart. Note that a minority of pathogenic variants in <i>KCNQ1</i> and <i>KCNE1</i> cause JLNS; the majority cause LQTS (see <a href="#jln.Differential_Diagnosis">Differential Diagnosis</a>).</p><ul><li class="half_rhythm"><div><i>KCNQ1</i> and <i>KCNE1</i> encode the alpha and beta subunit proteins (K<sub>V</sub>LQT1/minK) for the slow potassium current, I<sub>Ks</sub> of the cochlea and the heart.</div></li><li class="half_rhythm"><div>When stimulated by sound, potassium from the scala media of the cochlea passes through the apex of the hair cells, depolarizing the hair cells and causing a calcium-channel-induced release of neurotransmitter onto the auditory nerve. Depolarizations of the auditory nerve are sent centrally where they are perceived as sound. The maintenance of high potassium concentration in the endolymphatic fluid of the inner ear is required for normal hearing. The potassium-rich fluid of the scala media is created by the I<sub>Ks</sub> potassium channels (exclusively K<sub>V</sub>LQT1/minK) in the stria vascularis.</div></li><li class="half_rhythm"><div>Malfunction in these channels in the cochlea causes deafness.</div></li><li class="half_rhythm"><div>Malfunction in these channels in the heart results in abnormal ventricular electrical activity and LQTS.</div></li></ul><div id="jln.KCNQ1"><h4><i>KCNQ1</i></h4><p><b>Gene structure.</b>
<i>KCNQ1</i> consists of 16 exons spanning approximately 400 kb. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1405/#jln.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Nearly 30 of the more than 500 reported pathogenic variants in <i>KCNQ1</i> are associated with JLNS; ten result in frameshift and premature truncation [<a class="bk_pop" href="#jln.REF.tyson.2000.499">Tyson et al 2000</a>, <a class="bk_pop" href="#jln.REF.wang.2002.308">Wang et al 2002</a>, <a class="bk_pop" href="#jln.REF.ning.2003.246">Ning et al 2003</a>, <a class="bk_pop" href="#jln.REF.zehelein.2006.35397">Zehelein et al 2006</a>, <a class="bk_pop" href="#jln.REF.bhuiyan.2008.319">Bhuiyan et al 2008</a>, <a class="bk_pop" href="#jln.REF.ohno.2008.687">Ohno et al 2008</a>, <a class="bk_pop" href="#jln.REF.zhang.2008.24">Zhang et al 2008</a>, <a class="bk_pop" href="#jln.REF.baek.2010.1522">Baek et al 2010</a>, <a class="bk_pop" href="#jln.REF.wang.2011.41">Wang et al 2011</a>, <a class="bk_pop" href="#jln.REF.gao.2012.67">Gao et al 2012</a>]. Both <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> and <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> of one or more exons of <i>KCNQ1</i> are known to cause long QT syndrome [<a class="bk_pop" href="#jln.REF.zehelein.2006.35397">Zehelein et al 2006</a>, <a class="bk_pop" href="#jln.REF.eddy.2008.1275">Eddy et al 2008</a>, <a class="bk_pop" href="#jln.REF.sung.2014.395">Sung et al 2014</a>].</p><p>In individuals of Norwegian descent, it is important to confirm that <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> includes detection of the most common <i>KCNQ1</i> pathogenic variants reported in this population: c.573_577delGCGCT, p.Arg518Ter, and p.Gln530Ter [<a class="bk_pop" href="#jln.REF.tranebj_rg.1999.137">Tranebj&#x000e6;rg et al 1999</a>].</p><div id="jln.T.kcnq1_pathogenic_variants_discusse" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>KCNQ1</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1405/table/jln.T.kcnq1_pathogenic_variants_discusse/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__jln.T.kcnq1_pathogenic_variants_discusse_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_jln.T.kcnq1_pathogenic_variants_discusse_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:justify;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_jln.T.kcnq1_pathogenic_variants_discusse_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_jln.T.kcnq1_pathogenic_variants_discusse_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_jln.T.kcnq1_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:justify;vertical-align:middle;">c.1552C&#x0003e;T</td><td headers="hd_h_jln.T.kcnq1_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg518Ter&#x000a0;<sup>2</sup></td><td headers="hd_h_jln.T.kcnq1_pathogenic_variants_discusse_1_1_1_3" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_000218.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000218<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/protein/NP_000209.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000209<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_jln.T.kcnq1_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:justify;vertical-align:middle;">c.1588C&#x0003e;T</td><td headers="hd_h_jln.T.kcnq1_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln530Ter</td></tr><tr><td headers="hd_h_jln.T.kcnq1_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:justify;vertical-align:middle;">c.573_577delGCGCT<br />(572del5 or 575del5)</td><td headers="hd_h_jln.T.kcnq1_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg192CysfsTer91</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="jln.TF.2.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd><dt>2. </dt><dd><div id="jln.TF.2.2"><p class="no_margin">See <a href="#jln.Prevalence">Prevalence</a>.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The gene product is potassium voltage-gated channel subfamily KQT member 1 (also known as voltage-gated potassium channel protein KvLQT1); this alpha subunit has six transmembrane regions and forms a heteromultimer with the protein encoded by <i>KCNE1</i> to form the functional channel I<sub>Ks</sub>.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants in the gene result in premature truncation and inability to form multimers with the protein encoded by <i>KCNE1</i> to form the functional channel I<sub>Ks</sub>. In a mouse model, recessive variants may exhibit a <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> effect that is not clinically observed in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, suggesting post-translational processing effects in vivo [<a class="bk_pop" href="#jln.REF.thomas.2007.99">Thomas et al 2007</a>, <a class="bk_pop" href="#jln.REF.hothi.2009.819">Hothi et al 2009</a>].</p></div><div id="jln.KCNE1"><h4><i>KCNE1</i></h4><p><b>Gene structure.</b>
<i>KCNE1</i> consists of three exons spanning approximately 40 kb. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1405/#jln.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Four pathogenic variants associated with JLNS have been identified in <i>KCNE1</i>, all of which are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>. The majority of pathogenic variants in <i>KCNE1</i> are associated with <a href="/books/n/gene/rws/">LQTS</a>.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Potassium voltage-gated channel subfamily E member 1 (also known as minK potassium channel protein beta subunit) is a protein of 130 amino acids with one transmembrane region. It forms multimers with the protein encoded by <i>KCNQ1</i> to form the functional channel I<sub>Ks</sub>.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The specific effect of each <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> differs in the manner in which it impairs potassium channel function.</p></div></div></div><div id="jln.References"><h2 id="_jln_References_">References</h2><div id="jln.Published_GuidelinesConsensus_Statem"><h3>Published Guidelines/Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="jln.REF1">American College of Medical Genetics. Genetics evaluation guidelines for the etiologic diagnosis of congenital hearing loss. Genetic evaluation of congenital hearing loss expert panel. Available <a href="/pmc/articles/PMC3110944/" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2002. Accessed 7-30-18.</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF2">American College of Medical Genetics. Statement on universal newborn hearing screening. Available <a href="http://www.acmg.net/PDFLibrary/Universal-Newborn-Hearing-Screening.pdf" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2000. Accessed 7-30-18.</div></li></ul></div><div id="jln.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="jln.REF.ackerman.2017.e41">Ackerman MJ, Priori SG, Anne Dubin A, Kowey P, Linker NJ, Slotwiner D, Triedman J, Van Hare GF, Gold MR. Beta blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: are all beta blockers equivalent? <span><span class="ref-journal">Heart Rhythm. </span>2017;<span class="ref-vol">14</span>:e41–e44.</span> [<a href="/pubmed/27659101" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27659101</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.alaama.2015.74">Al-Aama JY, Al-Ghamdi S, Bdier AY, AlQarawi A, Jiman OA, Al-Aama N, Al-Aata J, Wilde AA, Bhuiyan ZA. Genotype-phenotype analysis of Jervell and Lange-Nielsen syndrome in six families from Saudi Arabia. <span><span class="ref-journal">Clin Genet. </span>2015;<span class="ref-vol">87</span>:74–9.</span> [<a href="/pubmed/24372464" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24372464</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.allan.2001.178">Allan WC, Timothy K, Vincent GM, Palomaki GE, Neveux LM, Haddow JE. Long QT syndrome in children: the value of the rate corrected QT interval in children who present with fainting. <span><span class="ref-journal">J Med Screen. </span>2001;<span class="ref-vol">8</span>:178–82.</span> [<a href="/pubmed/11743033" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11743033</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.baek.2010.1522">Baek JS, Bae EJ, Lee SY, Park SS, Kim SY, Jung KN, Noh CI. Jervell and Lange-Nielsen syndrome: novel compound heterozygous mutations in the KCNQ1 in a Korean family. <span><span class="ref-journal">J Korean Med Sci. </span>2010;<span class="ref-vol">25</span>:1522–5.</span> [<a href="/pmc/articles/PMC2946666/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2946666</span></a>] [<a href="/pubmed/20890437" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20890437</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.berge.2008.362">Berge KE, Haugaa KH, Fr&#x000fc;h A, Anfinsen O-G, Gjjesdaj K, Siem G, &#x000d8;yen N, Greve G, Carlsson A, Rognum TO, Hallerud M, Kongsg&#x000e5;rd E, Amlie JP, Leren TP. Molecular genetic analysis of long QT syndrome in Norway indicating a high prevalence of heterozygous mutation carriers. <span><span class="ref-journal">Scand J Clin Lab Invest. </span>2008;<span class="ref-vol">68</span>:362–8.</span> [<a href="/pubmed/18752142" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18752142</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.bhuiyan.2008.319">Bhuiyan ZA, Momenah TS, Amin AS, Al-Khadra AS, Alders M, Wilde AA, Mannens MM. An intronic mutation leading to incomplete skipping of exon-2 in KCNQ1 rescues hearing in Jervell and Lange-Nielsen syndrome. <span><span class="ref-journal">Prog Biophys Mol Biol. </span>2008;<span class="ref-vol">98</span>:319–27.</span> [<a href="/pubmed/19027783" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19027783</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.broomfield.2010.163">Broomfield SJ, Bruce IA, Henderson L, Green KMJ, Ramsden RT. Cochlear impantation in Jervell &#x00026; Lange-Nielsen syndrome: a cautionary report. <span><span class="ref-journal">Cochlear Implants Int. </span>2010;<span class="ref-vol">11</span>:163–5.</span> [<a href="/pubmed/21756604" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21756604</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.chang.2014">Chang RK, Lan YT, Silka MJ, Morrow H, Kwong A, Smith-Lang J, Wallerstein R, Lin HJ. Genetic variants for long QT syndrome among infants and children from a statewide newborn hearing screening program cohort. J Pediatr. 2014;164:590-5.e1-3. [<a href="/pmc/articles/PMC3943925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3943925</span></a>] [<a href="/pubmed/24388587" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24388587</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.chockalingam.2012.2092">Chockalingam P, Crotti L, Girardengo G, Johnson JN, Harris KM, van der Heijden JF, Hauer RNW, Beckmann BM, Spazzolini C, Rordorf R, Rydberg A, Clur SB, Fischer M, van den Heuvel F, Kaab S, Blom NA, Ackerman MJ, Schwartz PJ, Wilde AAM. Not All beta-blockers are equal in the management of long QT syndrome types 1 and 2. <span><span class="ref-journal">J Am Coll Cardiol. </span>2012;<span class="ref-vol">60</span>:2092–9.</span> [<a href="/pmc/articles/PMC3515779/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3515779</span></a>] [<a href="/pubmed/23083782" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23083782</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.chorbachi.2002.213">Chorbachi R, Graham JM, Ford J, Raine CH. Cochlear implantation in Jervell and Lange-Nielsen syndrome. <span><span class="ref-journal">Int J Pediatr Otorhinolaryngol. </span>2002;<span class="ref-vol">66</span>:213–21.</span> [<a href="/pubmed/12443809" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12443809</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.daneshi.2008.314">Daneshi A, Ghassemi MM, Talee M, Hassanzadeh S. Cochlear implantation in children with Jervell and Lange-Nielsen syndrpome. <span><span class="ref-journal">J Laryngol Otol. </span>2008;<span class="ref-vol">122</span>:314–7.</span> [<a href="/pubmed/17498328" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17498328</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.eddy.2008.1275">Eddy CA, MacCormick JM, Chung SK, Crawford JR, Love DR, Rees MI, Skinner JR, Shelling AN. Identification of large gene deletions and duplications in KCNQ1 and KCNH2 in patients with long QT syndrome. <span><span class="ref-journal">Heart Rhythm. </span>2008;<span class="ref-vol">5</span>:1275–81.</span> [<a href="/pubmed/18774102" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18774102</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.gao.2012.67">Gao Y, Li C, Liu W, Wu R, Qiu X, Liang R, Li L, Zhang L, Hu D. Genotype-phenotype analysis of three Chinese families with Jervell and Lange-Nielsen syndrome. <span><span class="ref-journal">J Cardiovasc Dis Res. </span>2012;<span class="ref-vol">3</span>:67–75.</span> [<a href="/pmc/articles/PMC3354473/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3354473</span></a>] [<a href="/pubmed/22629021" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22629021</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.goel.2004.370">Goel AK, Berger S, Pelech A, Dhala A. Implantable cardioverter defibrillator therapy in children with long QT syndrome. <span><span class="ref-journal">Pediatr Cardiol. </span>2004;<span class="ref-vol">25</span>:370–8.</span> [<a href="/pubmed/14994181" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14994181</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.goldenberg.2006.1161">Goldenberg I, Moss AJ, Zareba W, McNitt S, Robinson JL, Qi M, Towbin JA, Ackerman MJ, Murphy L. Clinical course and risk stratification of patients affected with the Jervell and Lange-Nielsen syndrome. <span><span class="ref-journal">J Cardiovasc Electrophysiol. </span>2006;<span class="ref-vol">17</span>:1161–8.</span> [<a href="/pubmed/16911578" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16911578</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.green.2000.27">Green JD, Schuh MJ, Maddern BR, Haymond J, Helffrich RA. Cochlear implantation in Jervell and Lange-Nielsen syndrome. <span><span class="ref-journal">Ann Otol Rhinol Laryngol Suppl. </span>2000;<span class="ref-vol">185</span>:27–8.</span> [<a href="/pubmed/11140992" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11140992</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.hazinski.2004.278">Hazinski MF, Markenson D, Neish S, Gerardi M, Hootman J, Nichol G, Taras H, Hickey R, Connor O, Potts R, van der Jagt J, Berger E, Schexnayder S, Garson A Jr S, Doherty A, Smith S, et al.  Response to cardiac arrest and selected life-threatening medical emergencies: the medical emergency response plan for schools: A statement for healthcare providers, policymakers, school administrators, and community leaders. <span><span class="ref-journal">Circulation. </span>2004;<span class="ref-vol">109</span>:278–91.</span> [<a href="/pubmed/14707021" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14707021</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.hothi.2009.819">Hothi SS, Thomas G, Killeen MJ, Grace AA, Huang CL. Empirical correlation of triggered activity and spatial and temporal re-entrant substrates with arrhythmogenicity in a murine model for Jervell and Lange-Nielsen syndrome. <span><span class="ref-journal">Pflugers Arch. </span>2009;<span class="ref-vol">458</span>:819–35.</span> [<a href="/pmc/articles/PMC2719739/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2719739</span></a>] [<a href="/pubmed/19430811" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19430811</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.ning.2003.246">Ning L, Moss AJ, Zareba W, Robinson J, Rosero S, Ryan D, Qi M. Novel compound heterozygous mutations in the KCNQ1 gene associated with autosomal recessive long QT syndrome (Jervell and Lange-Nielsen syndrome). <span><span class="ref-journal">Ann Noninvasive Electrocardiol. </span>2003;<span class="ref-vol">8</span>:246–50.</span> [<a href="/pubmed/14510661" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14510661</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.ocal.1997.401">Ocal B, Imamoglu A, Atalay S, Ercan Tutar H. Prevalence of idiopathic long QT syndrome in children with congenital deafness. <span><span class="ref-journal">Pediatr Cardiol. </span>1997;<span class="ref-vol">18</span>:401–5.</span> [<a href="/pubmed/9326683" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9326683</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.ohno.2008.687">Ohno S, Kubota T, Yoshida H, Tsuji K, Makiyama T, Yamada S, Kuga K, Yamaguchi I, Kita T, Horie M. A novel mutation associated with Jervell and Lange-Nielsen syndrome in a Japanese family. <span><span class="ref-journal">Circ J. </span>2008;<span class="ref-vol">72</span>:687–93.</span> [<a href="/pubmed/18441444" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18441444</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.olesen.2012.24">Olesen MS, Bentzen BH, Nielsen JB, Steffensen AB, David JP, Jabbari J, Jensen HK, Hauns&#x000f8; S, Svendsen JH, Schmitt N. Mutations in the potassium channel subunit KCNE1 are associated with early-onset familial atrial fibrillation. <span><span class="ref-journal">BMC Med Genet. </span>2012;<span class="ref-vol">13</span>:24.</span> [<a href="/pmc/articles/PMC3359244/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3359244</span></a>] [<a href="/pubmed/22471742" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22471742</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.piippo.2001.562">Piippo K, Swan H, Pasternack M, Chapman H, Paavonen K, Viitasalo M, Toivonen L, Kontula K. A founder mutation of the potassium channel KCNQ1 in long QT syndrome: implications for estimation of disease prevalence and molecular diagnostics. <span><span class="ref-journal">J Am Coll Cardiol. </span>2001;<span class="ref-vol">37</span>:562–8.</span> [<a href="/pubmed/11216980" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11216980</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.richter.2006.1169">Richter S, Brugada P. Risk-stratifying Jervell and Lange-Nielsen syndrome from clinical data. <span><span class="ref-journal">J Cardiovasc Electrophysiol. </span>2006;<span class="ref-vol">17</span>:1169–71.</span> [<a href="/pubmed/16987380" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16987380</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.schulzebahr.1997.267">Schulze-Bahr E, Wang Q, Wedekind H, Haverkamp W, Chen Q, Sun Y, Rubie C, H&#x000f6;rdt M, Towbin JA, Borggrefe M, Assmann G, Qu X, Somberg JC, Breithardt G, Oberti C, Funke H. KCNE1 mutations cause jervell and Lange-Nielsen syndrome. <span><span class="ref-journal">Nat Genet. </span>1997;<span class="ref-vol">17</span>:267–8.</span> [<a href="/pubmed/9354783" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9354783</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.schwartz.2000.262">Schwartz PJ, Priori SG, Dumaine R, Napolitano C, Antzelevitch C, Stramba-Badiale M, Richard TA, Berti MR, Bloise R. A molecular link between the sudden infant death syndrome and the long-QT syndrome. <span><span class="ref-journal">N Engl J Med. </span>2000;<span class="ref-vol">343</span>:262–7.</span> [<a href="/pubmed/10911008" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10911008</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.schwartz.2006.783">Schwartz PJ, Spazzolini C, Crotti L, Bathen J, Amlie JP, Timothy K, Shkolnikova M, Berul CI, Bitner-Glindzicz M, Toivonen L, Horie M, Schulze-Bahr E, Denjoy I. The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome. <span><span class="ref-journal">Circulation. </span>2006;<span class="ref-vol">113</span>:783–90.</span> [<a href="/pubmed/16461811" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16461811</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.seth.2007.1092">Seth R, Moss AJ, McNitt S, Zareba W, Andrews ML, Qi M, Robinson JL, Goldenberg I, Ackerman MJ, Benhorin J, Kaufman ES, Locati EH, Napolitano C, Priori SG, Schwartz PJ, Towbin JA, Vincent GM, Zhang L. Long QT syndrome and pregnancy. <span><span class="ref-journal">J Am Coll Cardiol. </span>2007;<span class="ref-vol">49</span>:1092–8.</span> [<a href="/pubmed/17349890" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17349890</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.siem.2008.261">Siem G, Fr&#x000fc;h A, Leren TP, Heimdal K, Teig E, Harris S. Jervell and Lange-Nielsen syndrome in Norwegian children: Aspects around cochlear implantation, hearing, and balance. <span><span class="ref-journal">Ear Hear. </span>2008;<span class="ref-vol">29</span>:261–9.</span> [<a href="/pubmed/18595190" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18595190</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.splawski.1997.1562">Splawski I, Timothy KW, Vincent GM, Atkinson DL, Keating MT. Molecular basis of the long-QT syndrome associated with deafness. <span><span class="ref-journal">N Engl J Med. </span>1997;<span class="ref-vol">336</span>:1562–7.</span> [<a href="/pubmed/9164812" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9164812</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.sung.2014.395">Sung JY, Bae EJ, Park S, Kim SY, Hyun YJ, Park SS, Seong MW. Large deletion in KCNQ1 identified in a family with Jervell and Lange-Nielsen syndrome. <span><span class="ref-journal">Ann Lab Med. </span>2014;<span class="ref-vol">34</span>:395–8.</span> [<a href="/pmc/articles/PMC4151011/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4151011</span></a>] [<a href="/pubmed/25187895" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25187895</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.thomas.2007.99">Thomas G, Killeen MJ, Gurung IS, Hakim P, Balasubramaniam R, Goddard CA, Grace AA, Huang CL. Mechanisms of ventricular arrhythmogenesis in mice following targeted disruption of KCNE1 modelling long QT syndrome 5. <span><span class="ref-journal">J Physiol. </span>2007;<span class="ref-vol">578</span>:99–114.</span> [<a href="/pmc/articles/PMC2075126/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2075126</span></a>] [<a href="/pubmed/17095567" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17095567</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.towbin.2001.574">Towbin JA, Wang Z, Li H. Genotype and severity of long QT syndrome. <span><span class="ref-journal">Drug Metab Dispos. </span>2001;<span class="ref-vol">29</span>:574–9.</span> [<a href="/pubmed/11259355" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11259355</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.tranebj_rg.2004">Tranebj&#x000e6;rg L. Jervell and Lange-Nielsen syndrome. In: Willems PJ, ed. <em>Genetic Hearing Loss</em>. New York, NY: Marcel Dekker Publications; 2004:117-34.</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.tranebj_rg.1999.137">Tranebj&#x000e6;rg L, Bathen J, Tyson J, Bitner-Glindzicz M. Jervell and Lange-Nielsen syndrome: a Norwegian perspective. <span><span class="ref-journal">Am J Med Genet. </span>1999;<span class="ref-vol">89</span>:137–46.</span> [<a href="/pubmed/10704188" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10704188</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.tyson.1997.2179">Tyson J, Tranebjaerg L, Bellman S, Wren C, Taylor JF, Bathen J, Aslaksen B, S&#x000f8;rland SJ, Lund O, Malcolm S, Pembrey M, Bhattacharya S, Bitner-Glindzicz M. IsK and KvLQT1: mutation in either of the two subunits of the slow component of the delayed rectifier potassium channel can cause Jervell and Lange-Nielsen syndrome. <span><span class="ref-journal">Hum Mol Genet. </span>1997;<span class="ref-vol">6</span>:2179–85.</span> [<a href="/pubmed/9328483" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9328483</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.tyson.2000.499">Tyson J, Tranebj&#x000e6;rg L, McEntagart M, Larsen LA, Christiansen M, Whiteford ML, Bathen J, Aslaksen B, Sorland SJ, Lund O, Pembrey ME, Malcolm S, Bitner-Glindzicz M. Mutational spectrum in the cardioauditory syndrome of Jervell and Lange-Nielsen. <span><span class="ref-journal">Hum Genet. </span>2000;<span class="ref-vol">107</span>:499–503.</span> [<a href="/pubmed/11140949" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11140949</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.wang.2011.41">Wang RR, Li N, Zhang YH, Wang LL, Teng SY, Pu JL. Novel compound heterozygous mutations T2C and 1149insT in the KCNQ1 gene cause Jervell and Lange-Nielsen syndrome. <span><span class="ref-journal">Int J Mol Med. </span>2011;<span class="ref-vol">28</span>:41–6.</span> [<a href="/pubmed/21380488" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21380488</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.wang.2002.308">Wang Z, Li H, Moss AJ, Robinson J, Zareba W, Knilans T, Bowles NE, Towbin JA. Compound heterozygous mutations in KvLQT1 cause Jervell and Lange-Nielsen syndrome. <span><span class="ref-journal">Mol Genet Metab. </span>2002;<span class="ref-vol">75</span>:308–16.</span> [<a href="/pubmed/12051962" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12051962</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.winbo.2012.1799">Winbo A, Stattin EL, Diamant UB, Persson J, Jensen SM, Rydberg A. Prevalence, mutation spectrum, and cardiac phenotype of the Jervell and Lange-Nielsen syndrome in Sweden. <span><span class="ref-journal">Europace. </span>2012;<span class="ref-vol">14</span>:1799–806.</span> [<a href="/pubmed/22539601" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22539601</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.winbo.2013.325">Winbo A, Sandstr&#x000f6;m O, Palmqvist R, Rydberg A. Iron-deficiency anaemia, gastric hyperplasia, and elevated gastrin levels due to potassium channel dysfunction in the Jervell and Lange-Nielsen Syndrome. <span><span class="ref-journal">Cardiol Young. </span>2013;<span class="ref-vol">23</span>:325–34.</span> [<a href="/pubmed/22805636" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22805636</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.winbo.2014.22">Winbo A, Stattin E-L, Nordin C, Diamant UB, Persson J, Jensen SM, Rydberg A. Phenotype, origin and estimated prevalence of a common long QT syndrome mutation: a clinical, genealogical and molecular genetics study including Swedish R518X/KCNQ1 families. <span><span class="ref-journal">BMC Cardiovasc Disord. </span>2014;<span class="ref-vol">14</span>:22.</span> [<a href="/pmc/articles/PMC3942207/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3942207</span></a>] [<a href="/pubmed/24552659" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24552659</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.winbo.2015.7">Winbo A, Rydberg A. Vestibular dysfunction is a clinical feature of Jervell and Lange-Nielsen Syndrome. <span><span class="ref-journal">Scand Cardiovasc J. </span>2015;2015;<span class="ref-vol">49</span>:7–13.</span> [<a href="/pubmed/25471708" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25471708</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.yanmei.2008.1723">Yanmei F, Yagin W, Haibo S, Huiqun Z, Zhengnong C, Dongzhen Y, Shankai Y. Cochlear implantation in patients with Jervell and Lange_Nielsen syndrome, and a review of the literature. <span><span class="ref-journal">Int J Pediatr Otorhinolaryngol. </span>2008;<span class="ref-vol">72</span>:1723–9.</span> [<a href="/pubmed/18805595" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18805595</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.zehelein.2006.35397">Zehelein J, Kathoefer S, Khalil M, Alter M, Thomas D, Brockmeier K, Ulmer HE, Katus HA, Koenen M. Skipping of exon 1 in the KCNQ1 gene causes Jervell and Lange-Nielsen Syndrome. <span><span class="ref-journal">J Biol Chem. </span>2006;<span class="ref-vol">281</span>:35397–403.</span> [<a href="/pubmed/16987820" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16987820</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jln.REF.zhang.2008.24">Zhang S, Yin K, Ren X, Wang P, Zhang S, Cheng L, Yang J, Liu JY, Liu M, Wang QK. Identification of a novel KCNQ1 mutation associated with both Jervell and Lange-Nielsen and Romano-Ward forms of long QT syndrome in a Chinese family. <span><span class="ref-journal">BMC Med Genet. </span>2008;<span class="ref-vol">9</span>:24.</span> [<a href="/pmc/articles/PMC2322962/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2322962</span></a>] [<a href="/pubmed/18400097" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18400097</span></a>]</div></li></ul></div><div id="jln.Suggested_Reading"><h3>Suggested Reading</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="jln.REF.cave.2011.691">Cave DM, Aufderheide TP, Beeson J, Ellison A, Gregory A, Hazinski MF, Hiratzka LF, Lurie KG, Morrison LJ, Mosesso VN Jr, Nadkarni V, Potts J, Samson RA, Sayre MR, Schexnayder SM, et al.  Importance and implementation of training in cardiopulmonary resuscitation and automated external defibrillation in schools: a science advisory from the American Heart Association. <span><span class="ref-journal">Circulation. </span>2011;<span class="ref-vol">123</span>:691–706.</span> [<a href="/pubmed/21220728" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21220728</span></a>]</div></li></ul></div></div><div id="jln.Chapter_Notes"><h2 id="_jln_Chapter_Notes_">Chapter Notes</h2><div id="jln.Author_History"><h3>Author History</h3><p>Shane M Daley, MD; Mayo Clinic-Scottsdale (2002-2010)<br />Glenn Edward Green, MD (2002-present)<br />Ricardo A Samson, MD (2002-present)<br />Lisbeth Tranebj&#x000e6;rg, MD, PhD (2002-present)</p></div><div id="jln.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>17 August 2017 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>20 November 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>4 October 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>23 February 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>19 March 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>29 July 2004 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>13 January 2003 (gg) Revision: Molecular Genetic Testing</div></li><li class="half_rhythm"><div>29 July 2002 (me) Review posted live</div></li><li class="half_rhythm"><div>8 October 2001 (gg) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1405</span><span class="label">PMID: <a href="/pubmed/20301579" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301579</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/iso-def/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/joubert/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1405&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1405/?report=reader">PubReader</a></li><li><a href="/books/NBK1405/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1405" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1405" style="display:none" title="Cite this Page"><div class="bk_tt">Tranebjærg L, Samson RA, Green GE. Jervell and Lange-Nielsen Syndrome. 2002 Jul 29 [Updated 2017 Aug 17]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1405/pdf/Bookshelf_NBK1405.pdf">PDF version of this page</a> (470K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#jln.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#jln.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#jln.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#jln.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#jln.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#jln.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#jln.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#jln.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#jln.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#jln.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#jln.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3753[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KCNE1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3784[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KCNQ1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1498090" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1498090" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1498090" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1498090" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301308" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Long QT Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Long QT Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Alders M, Bikker H, Christiaans I. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301466" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Catecholaminergic Polymorphic Ventricular Tachycardia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Catecholaminergic Polymorphic Ventricular Tachycardia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Napolitano C, Priori SG, Bloise R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23400408" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Jervell and Lange-Nielsen syndrome: homozygous missense mutation of KCNQ1 in a Turkish family.</a><span class="source">[Pediatr Cardiol. 2013]</span><div class="brieflinkpop offscreen_noflow">Jervell and Lange-Nielsen syndrome: homozygous missense mutation of KCNQ1 in a Turkish family.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bostan O, Temel ŞG, Cangül H, Archer CN, Çil E. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Pediatr Cardiol. 2013; 34(8):2063-7. Epub 2013 Feb 12.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/26022593" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Jervell and Lange-Nielsen syndrome with homozygous missense mutation of the KCNQ1 gene.</a><span class="source">[Turk J Pediatr. 2014]</span><div class="brieflinkpop offscreen_noflow">Jervell and Lange-Nielsen syndrome with homozygous missense mutation of the KCNQ1 gene.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kılıç E, Ertuğrul İ, Özer S, Alikaşifoğlu M, Aktaş D, Boduroğlu K, Ütine GE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Turk J Pediatr. 2014 Sep-Oct; 56(5):542-5. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28364778" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Clinical and molecular findings in a Moroccan family with Jervell and Lange-Nielsen syndrome: a case report.</a><span class="source">[J Med Case Rep. 2017]</span><div class="brieflinkpop offscreen_noflow">Clinical and molecular findings in a Moroccan family with Jervell and Lange-Nielsen syndrome: a case report.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Adadi N, Lahrouchi N, Bouhouch R, Fellat I, Amri R, Alders M, Sefiani A, Bezzina C, Ratbi I. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Med Case Rep. 2017 Apr 2; 11(1):88. Epub 2017 Apr 2.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301579" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301579" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc8fde39a66ee2baa473c0">Jervell and Lange-Nielsen Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Jervell and Lange-Nielsen Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:09:50-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE89310DDFC89BC100000000030C0174&amp;ncbi_session=CE89310DDFC8FDD1_0780SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1405%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1405&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1405/&amp;ncbi_pagename=Jervell and Lange-Nielsen Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE89310DDFC8FDD1_0780SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>